NCT00720603
This is a Multi-center, Single Arm, Open Label Study Intended to Provide Expanded Access to Plerixafor for Patients With Non-Hodgkin's Lymphoma (NHL), Hodgkin's Disease (HD) or Multiple Myeloma (MM) Who Are to Receive Treatment With an Autologous Peripheral Stem Cell Transplant. Not Available Not Available no_longer_available NCT03138499
A Study of Nivolumab Plus Brentuximab Vedotin Versus Brentuximab Vedotin Alone in Patients With Advanced Stage Classical Hodgkin Lymphoma, Who Are Relapsed/ Refractory or Who Are Not Eligible for Autologous Stem Cell Transplant, treatment 3 terminated NCT02007811
Open-label Clinical Trial to Investigate the Safety and Tolerability of Allogeneic B-cell Concentrates for Immune Reconstitution After Allogeneic Stem Cell Transplantation Measured as Response to a Antedated Single Vaccination No drug interventions treatment 1 / 2 unknown_status NCT01904175
Registry Study of T Cell Depleted Allo Non-Myeloablative Stem Cell Transplant No drug interventions Not Available Not Available completed NCT01890486
The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen No drug interventions Not Available Not Available recruiting NCT01702961
Rituxan + BEAM and Auto Stem Cell Transplant for High Risk Lymphoma or Hodgkin's Disease treatment Not Available completed NCT01315132
A Study of Bone Marrow Transplantation Using Fully-Matched Relatives as Donors for Patients With Hematological Malignancies No drug interventions treatment 2 completed NCT01188798
Methotrexate or Pentostatin for Graft-versus-host Disease Prophylaxis in Risk-adapted Allogeneic Bone Marrow Transplantation for Hematologic Malignancies treatment 3 completed NCT01085058
Predictive Value of the "Cytocapacity Test" Patients With Lymphoproliferative Diseases and High-dose Therapy diagnostic 2 / 3 completed NCT00975975
Basiliximab #2: In-Vivo Activated T-Cell Depletion to Prevent Graft-Versus_Host Disease (GVHD) After Nonmyeloablative Allotransplantation for the Treatment of Blood Cancer treatment 2 completed NCT00990587
Study Evaluating the Tolerance and Biologic Activity of Oral Ciclopirox Olamine in Patients With Relapsed or Refractory Hematologic Malignancy treatment 1 completed NCT00990717
Safety Study Looking at the Use of a Natural Killer Cell Line Against Hematological Malignancies treatment 1 completed NCT00698685
Pentostatin and Alemtuzumab as a Preparative Regimen for Allogeneic Peripheral Blood Stem Cell Transplantation treatment 2 terminated NCT00667615
Trial of Vorinostat in Combination With Cyclophosphamide, Etoposide, Prednisone and Rituximab for Elderly Patients With Relapsed Diffuse Large B-Cell Lymphoma (DLBCL) treatment 1 / 2 completed NCT00606437
Total Body Irradiation With Fludarabine Followed by Combined Umbilical Cord Blood (UCB) Transplants No drug interventions treatment 1 completed NCT00579917
Behavioral Intervention For BMT/SCT Survivors No drug interventions Not Available Not Available completed NCT00581815
Spectroscopy With Surface Coils and Decoupling No drug interventions diagnostic 1 completed NCT00551798
Prediction of the Response to Chemotherapy by Tomoscintigraphie the MIBI in the Balance Sheet Pre Hodgkin's Disease and Lymphoma Malins High Grade No drug interventions diagnostic Not Available completed NCT00552825
Pulmonary Function at Presentation and Follow-up in Hemato-Oncology 3-7 Years Old Children No drug interventions Not Available Not Available completed NCT00385788
Allogeneic Blood Stem Cell Transplantation and Adoptive Immunotherapy for Hodgkin's Disease treatment 2 completed NCT00398177
Clinical and Pathologic Studies in Non-Hodgkin's Lymphoma and Hodgkin's Disease No drug interventions Not Available Not Available recruiting NCT00176930
Stem Cell Transplant for Hematological Malignancy treatment Not Available terminated NCT00163761
Efficacy Study of Outpatient Therapy for Lymphoma treatment 2 completed NCT00163748
Efficacy and Treatment Related Toxicity Study of a New Regimen for Lymphoma treatment 2 completed NCT00144677
Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Un-Related Stem Cell Transplantation prevention 2 completed NCT00129753
Alemtuzumab (Campath-1H) Monoclonal Antibody in Patients With Relapsed and Resistant Classical Hodgkin's Disease treatment 2 withdrawn NCT00038818
CD8 DLI for Patients With Relapse or Residual Disease Following Allogeneic Stem Cell Transplantation No drug interventions treatment Not Available terminated NCT00001575
Anti-Tac(90 Y-HAT) to Treat Hodgkin's Disease, Non-Hodgkin's Lymphoma and Lymphoid Leukemia No drug interventions treatment 1 / 2 completed NCT00001430
A Randomized Study of EPOCH II Versus EPOCH II and Immunotherapy in Lymphomas No drug interventions treatment 2 completed NCT02856646
Hodgkin Lymphoma Molecular Profiling and Clinical Outcomes in U.S. Community Oncology Practices No drug interventions Not Available Not Available completed NCT02639559
Safety and Efficacy of BL-8040 for the Mobilization of Donor Hematopoietic Stem Cells and Allogeneic Transplantation in Patients With Advanced Hematological Malignancies treatment 2 completed NCT01833884
Kinetic of Cytokines Decrease and Hodgkin Lymphoma Prognostic No drug interventions diagnostic Not Available completed NCT01696461
A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor treatment 2 completed NCT01555892
Cytotoxic T-Lymphocytes for EBV-positive Lymphoma, GRALE No drug interventions treatment 1 recruiting NCT01527838
Single Treatment With FT1050 of an Ex-vivo Modulated Umbilical Cord Blood Unit No drug interventions treatment 1 completed NCT01499147
Fludarabine Based Conditioning for Allogeneic Transplantation for Advanced Hematologic Malignancies treatment Not Available completed NCT01458288
A Study to Evaluate the Safety, Pharmacokinetics, and Hematopoietic Stem Cell Mobilization of TG-0054 Alone or in Combination With G-CSF in Patients With Multiple Myeloma, Non-Hodgkin Lymphoma or Hodgkin Disease treatment 2 completed NCT01350245
Bone Marrow Transplantation of Patients in Remission Using Partially Matched Relative Donor treatment 2 completed NCT01221857
Pilot Study Evaluating Safety & Efficacy of DCBT: NiCord® & UNM CBU to Patients With Hematological Malignancies treatment 1 / 2 completed NCT01045382
MSC and HSC Coinfusion in Mismatched Minitransplants No drug interventions treatment 2 terminated NCT00952237
Immune Mobilization of Autologous Peripheral Blood Stem Cells Using Interleukin-2 and GM-CSF treatment 1 completed NCT00935597
Host Dendritic Cells in Allograft Patients No drug interventions treatment 1 unknown_status NCT00718757
Irinotecan, Vincristine, and Dexamethasone In Children With Relapsed And/Or Refractory Hematologic Malignancies treatment 1 completed NCT00685997
Whole-body Magnetic Resonance Imaging (MRI) for Staging Malignant Lymphomas No drug interventions Not Available Not Available completed NCT00598728
Quality of Life Among Survivors of Hodgkin Lymphoma No drug interventions Not Available Not Available completed NCT00648037
Rituximab (Rituxan) for the Prevention of EBV-LPD Epstein Barr Virus (EBV) Lymphoproliferative Disorder Post T Cell Depleted Unrelated and HLA Mis-matched Related HSCT treatment Not Available completed NCT00608452
Prevalence+Significance of Paraneoplastic Autoantibodies in Many Cancers No drug interventions Not Available Not Available completed NCT00569842
Investigation of the Cylex® ImmuKnow® Assay No drug interventions Not Available Not Available completed NCT00592111
A Comprehensive Study of Clinically Staged Pediatric Hodgkin's Disease: Chemotherapy for All Patients; Supplementary Low Dose Involved Field Irradiation for Selected Patients (CCG 5942) treatment 2 completed NCT00594308
In-Vivo Activated T-Cell Depletion to Prevent GVHD treatment Not Available terminated NCT00469729
Efficacy and Safety Study of StemEx®, to Treat Subjects With High Risk Hematologic Malignancies, Following Myeloablative Therapy treatment 2 / 3 completed NCT00460694
Allogeneic Cytokine-induced Killer Immunotherapy for Relapse After Allogeneic Marrow Transplant for Haematological Malignancies No drug interventions treatment 1 / 2 completed NCT00423709
Allogeneic Blood Stem Cell Transplantation treatment Not Available completed NCT00396201
AMD3100 (Plerixafor) Added to a Mobilizing Regimen of Granulocyte-colony Stimulating Factor (G-CSF) to Increase the Number of Peripheral Blood Stem Cells (PBSCs) in Patients With Hodgkin's Disease treatment 2 completed NCT00368082
Autologous/Allogeneic TGFbeta-resistant LMP-specific CTL, Lymphoma (TGF-beta) No drug interventions treatment 1 active_not_recruiting NCT00343564
A Study of SB-743921 in Non-Hodgkin Lymphoma and Hodgkin Lymphoma treatment 1 / 2 completed NCT00209014
Phase II Trial of Thalidomide in Refractory/Relapsed Diffuse Large B-Cell Lymphoma and Hodgkin's Disease treatment 2 terminated NCT00232440
Reproducibility of an Immobilization Device (BodyFIX) - Hodgkins/Lymphoma No drug interventions treatment 1 / 2 completed NCT00165438
Pulmonary Function in Patients With Hodgkin's Disease Receiving Bleomycin-Based Chemotherapy No drug interventions Not Available Not Available completed NCT00165308
Tamoxifen in the Prevention of Breast Cancer in Hodgkin's Disease Survivors prevention Not Available completed NCT00131014
Establishing a Tumor Bank in Families With Multiple Lymphoproliferative Malignancies No drug interventions Not Available Not Available recruiting NCT00136474
Amifostine for Head and Neck Irradiation in Lymphoma treatment 2 completed NCT00144703
Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Related Stem Cell Transplantation prevention 2 completed NCT00133367
Study of Unrelated Cord Blood Transplantation Using Tacrolimus and Sirolimus treatment 2 completed NCT00147875
Study of Prednisone, Vinblastine, Doxorubicin, and Gemcitabine in Elderly Patients With Advanced Stages Hodgkin's Lymphoma treatment 1 / 2 completed NCT02087657
Pilot Study Exploring the Use of Hyperbaric Oxygen in Autologous Peripheral Blood Stem Cell Transplantation No drug interventions treatment Not Available unknown_status NCT01854567
P3 Study of Umbilical Cord Blood Cells Expanded With MPCs for Transplantation in Patients With Hematologic Malignancies No drug interventions treatment 3 completed NCT01665768
Maintenance Rituximab With mTor Inhibition After High-dose Consolidative Therapy in Lymphoma treatment 2 completed NCT01336712
Total Body Irradiation/Fludarabine Based Ablative Haploidentical Transplant for Hematologic Diseases No drug interventions treatment 2 completed NCT01321346
A Study Of Panobinostat In Children With Refractory Hematologic Malignancies treatment 1 completed NCT01283776
Cyclophosphamide as Sole Graft-Versus-Host-Prophylaxis After Allogeneic Stem Cell Transplantation prevention 2 completed NCT00924131
Evaluation of Late Treatment Effects in Long-Term Survivors of Hodgkin's Disease Previously Treated at NIH: A Multi-Institutional Trial No drug interventions Not Available Not Available completed NCT00891592
Umbilical Cord Blood Transplant for Hematological Malignancies No drug interventions treatment 1 completed NCT00797472
Study Comparing R-mabHD and a Combination of ABVD in Hodgkin's Disease treatment 2 unknown_status NCT00683046
T-Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Hematologic Malignancies treatment 2 completed NCT00665314
Evaluation of the Safety and Efficacy of the Addition of AMD3100 to a G-CSF Mobilization Regimen in Patients With Lymphoma (NHL and HD) and Multiple Myeloma (MM). treatment 2 completed NCT00705250
Bendamustine HCL in Relapsed and Primary Refractory Hodgkin Lymphoma treatment 2 completed NCT00691210
Phase I Vorinostat in Combination With Niacinamide and Etoposide for Lymphoid Malignancies treatment 1 completed NCT00674427
Trial of Donor Lymphocyte Infusion (DLI) and Activated DLI Following Relapse After Allogeneic Stem Cell Transplant No drug interventions treatment 1 terminated NCT00652626
Pharmacokinetics and Safety Study of Azacitidine in Cancer Patients With and Without Impaired Renal Function other 1 completed NCT00597714
Efficacy Study of T Cell Depleted Allogeneic Non-myeloablative Stem Cell Transplant No drug interventions treatment 2 completed NCT00587873
Sequential Administration of Oral 6-Thioguanine (6-TG) After Methotrexate (MTX) in Patients With Relapsed Hodgkin's Disease (Phase II) treatment 2 completed NCT00484874
Safety and Efficacy Study of I-131 Tositumomab in Patients With Relapsed/Refractory Hodgkin's Lymphoma treatment 1 / 2 completed NCT00386217
Psychosocial Impact of Cancer-Related Female Infertility No drug interventions Not Available Not Available completed NCT00284804
A Phase II Study of MDX-060 in Subjects With Relapsed or Refractory Hodgkin's Disease treatment 2 completed NCT00256191
Study of TPI 287 Administered Every 21 Days in Patients With Advanced Malignancies treatment 1 completed NCT00179816
Tandem Peripheral Blood Stem Cell (PBSC) Rescue for High Risk Solid Tumors treatment 1 / 2 unknown_status NCT00185692
Allogeneic Transplantation From Related Haploidentical Donors treatment 2 completed NCT00165425
Cardiac Screening in Survivors of Hodgkin's Disease Treated With Mediastinal Irradiation No drug interventions diagnostic Not Available active_not_recruiting NCT00165412
Breast MRI Screening in Women Treated With Mediastinal Irradiation for Hodgkin's Disease No drug interventions Not Available Not Available completed NCT00150462
Safety Study of the Proteasome Inhibitor PR-171 (Carfilzomib for Injection) in Patients With Hematological Malignancies treatment 1 completed NCT00165269
Mantle Irradiation for Hodgkin's Disease No drug interventions treatment 2 completed NCT00001830
Donor Th2 Cells to Prevent Graft-Versus-Host Disease in Bone Marrow Transplants No drug interventions treatment 1 completed NCT00000626
Phase II Study of Filgrastim (G-CSF) Plus ABVD in the Treatment of HIV-Associated Hodgkin's Disease treatment 2 completed NCT02200380
A Safety and Tolerability Study of CDX-301 With or Without Plerixafor for Stem Cell Mobilization in Matched Related Allogeneic Donor/Recipient Sibling Transplant Pairs treatment 2 terminated NCT01100502
A Phase 3 Study of Brentuximab Vedotin (SGN-35) in Patients at High Risk of Residual Hodgkin Lymphoma Following Stem Cell Transplant (The AETHERA Trial) treatment 3 completed NCT00649584
A Phase I Dose Escalation Study of SGN-35 Alone and in Combination With Gemcitabine for CD30-Positive Malignancies treatment 1 terminated NCT01026415
Clinical Pharmacology Study of Brentuximab Vedotin (SGN-35) treatment 1 completed NCT01196208
A Treatment-Option Protocol to Provide Brentuximab Vedotin to Eligible Patients Completing Studies SGN35-005 or C25001 Not Available Not Available no_longer_available NCT01026233
Cardiac Safety Study of Brentuximab Vedotin (SGN-35) treatment 1 completed NCT00947856
A Brentuximab Vedotin Trial for Patients Who Have Previously Participated in a Brentuximab Vedotin Study treatment 2 completed NCT00848926
A Pivotal Open-Label Trial of Brentuximab Vedotin for Hodgkin Lymphoma treatment 2 completed NCT01060904
A Phase 1 Study of Brentuximab Vedotin Combined With Multi-Agent Chemotherapy for Hodgkin Lymphoma treatment 1 completed NCT00430846
Phase I Open-Label Dose Finding Study of SGN-35 for CD30 Positive Hematologic Malignancies treatment 1 completed NCT01500161
Pooled Unrelated Donor Umbilical Cord Blood Transplant For Hematologic Malignancy Needing Allogeneic Stem Cell Transplant Without Related HLA-Match treatment 2 terminated NCT02070393
Breast-Sparing Proton Therapy for Hodgkin's Disease No drug interventions treatment 0 terminated NCT00802113
Autologous and Allogeneic Transplant for Relapsed Lymphoma treatment 1 / 2 completed NCT00713882
Health and Psychosocial Outcomes in Long-Term Lymphoma Survivors No drug interventions Not Available Not Available completed NCT00697684
Reduced Intensity Conditioning With Clofarabine, Antithymocyte Globulin (ATG), Total Lymphoid Irradiation (TLI) Followed by Allogeneic Stem Cell Transplant treatment 1 completed NCT01951885
Tac, Mini-MTX, MMF Versus Tac, MTX for GVHD Prevention supportive_care 3 completed NCT00754286
A Randomized Trial of The Effectiveness of Aromatherapy on Chemotherapy Induced Nausea and Vomiting in Children With Cancer No drug interventions supportive_care Not Available completed NCT00901225
Study of Plerixafor for Rescue of Poor Mobilizers in Autologous Stem Cell Transplant treatment 2 completed NCT00364676
Study of Vinorelbine Liposomes Injection for Advanced Solid Tumors, Non-Hodgkin's Lymphoma or Hodgkin's Disease No drug interventions treatment 1 completed NCT00571662
Safety and Efficacy of Pentostatin and Low Dose TBI With Allogenic Peripheral Blood Stem Cell Transplant treatment 2 completed NCT00764829
Blood Samples to Evaluate Biomarkers of Donor Chimerism No drug interventions Not Available Not Available completed NCT05255601
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of Relatlimab Plus Nivolumab in Pediatric and Young Adults With Hodgkin and Non-Hodgkin Lymphoma treatment 1 / 2 recruiting NCT06120504
A Safety Study of SGN-35T in Adults With Advanced Cancers No drug interventions treatment 1 recruiting NCT00039676
Clinical, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Hematologic Cancer No drug interventions Not Available Not Available active_not_recruiting NCT01676805
Tissue Collection for Studies of Lymph Cancer No drug interventions Not Available Not Available recruiting NCT02682667
Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols No drug interventions Not Available Not Available recruiting NCT04998331
A Spanish Medical Record Review of Adults With Relapsed or Refractory CD30+ Malignancies When Re-treated With Brentuximab-vedotin No drug interventions Not Available Not Available completed NCT06254495
A Safety Study of SGN-35C in Adults With Advanced Cancers No drug interventions treatment 1 recruiting NCT00903890
Cardiac Effects in Long-Term Survivors of Hodgkin's and Non-Hodgkin's Lymphoma No drug interventions Not Available Not Available completed NCT03739502
A Randomized Phase II Study of Hyperbaric Oxygen in Improving Engraftment in Umbilical Cord Blood Stem Cell Transplant No drug interventions treatment 2 recruiting NCT01956084
Cytotoxic T Cells to Treat Relapsed EBV-positive Lymphoma No drug interventions treatment 1 active_not_recruiting NCT00724984
Study of the Safety and Tolerability of PCI-24781 in Patients With Lymphoma treatment 1 / 2 completed NCT00779584
A Dose-escalation Study of MK-8776 (SCH 900776) With and Without Gemcitabine in Participants With Solid Tumors or Lymphoma (MK-8776-002/P05248) treatment 1 completed NCT01018979
Safety and PK/PD of TG-0054 in Multiple Myeloma, Non-Hodgkin Lymphoma and Hodgkin Disease Patients No drug interventions treatment 2 completed NCT01874054
Study of Brentuximab Vedotin Combined With Bendamustine in Patients With Hodgkin Lymphoma treatment 1 / 2 completed NCT00538551
Prospective Data Collection of Newly Diagnosed Hodgkin's Disease and Non-Hodgkin's Lymphoma Cases No drug interventions Not Available Not Available unknown_status NCT02567851
A Study of Brentuximab Vedotin in Patients With Hodgkin Lymphoma Unsuitable for Chemotherapy Due to Age, Frailty or Co-morbidity treatment 2 completed NCT01555853
Phase I/II Study of Abraxane in Recurrent and Refractory Lymphoma treatment 1 terminated NCT00261677
A Study to Evaluate the Effect of Weekly PROCRIT (Epoetin Alfa) or Placebo on Anemia and Quality of Life in Children With Cancer Undergoing Chemotherapy treatment 3 completed NCT00916045
Pilot Study of Unrelated Cord Blood Transplantation treatment 2 terminated NCT04671693
A Post-treatment Program to Identify and Manage Complications Related to Oncology or Hematology Treatments in Cancer Survivors. No drug interventions prevention Not Available recruiting NCT04072393
Cardiac Rehabilitation for Patients Receiving Radiation Therapy for Thoracic Cancers No drug interventions supportive_care Not Available terminated NCT02057185
Occupational Status and Hematological Disease No drug interventions Not Available Not Available completed NCT00196885
Effect of an Antioxidant on Cancer-Cachectic Patients Undergoing Exercise Training treatment 2 completed NCT01188915
Personalised Program for Women Treated for Hodgkin Disease No drug interventions prevention Not Available terminated NCT02378337
Defining PET / CT Protocols With Optimized F18-FDG (Fluorodeoxyglucose) Dose, Focusing on Reduced Radiation Dose and Improved Image Quality No drug interventions Not Available Not Available completed NCT00478959
Phase II Study of Lenalidomide for the Treatment of Relapsed or Refractory Hodgkin's Lymphoma treatment 2 completed NCT01141959
Blood Samples to Identify Biomarkers in Haploidentical Graft Recipients No drug interventions Not Available Not Available completed NCT01758042
Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders No drug interventions treatment Not Available recruiting NCT02376699
Safety Study of SEA-CD40 in Cancer Patients treatment 1 terminated NCT00145613
Haploidentical Stem Cell Transplant for Treatment Refractory Hematological Malignancies No drug interventions treatment 2 completed NCT02181218
Phase I Study of Romidepsin, Gemcitabine, Oxaliplatin, and Dexamethasone in Patients With Relapsed/Refractory Aggressive Lymphomas treatment 1 completed NCT01158118
Plerixafor and Sargramostim (GM-CSF) for Mobilization of Allogeneic Sibling Donors treatment 2 completed NCT00733824
Intravenous AMD3100 for Collection of Autologous Peripheral Blood Stem Cells in Patients With Lymphoma treatment 1 / 2 completed NCT00241358
Study Evaluating AMD3100 for Transplantation of Sibling Donor Stem Cells in Patients With Hematological Malignancies treatment 1 / 2 completed NCT00038558
Prophylactic Use of Filgrastim SD/01 in Patients With Hodgkin's Disease Receiving ABVD Chemotherapy treatment 3 completed NCT00514722
Pilot Study of Umbilical Cord Blood Transplantation in Adult Patient With Advanced Hematopoietic Malignancies No drug interventions treatment Not Available terminated NCT01858922
Chemotherapy With or Without Radiation, Low and Intermediate Risk Hodgkins Lymphoma, TXCH-HD-12A treatment 2 completed NCT02979522
A Study of Brentuximab Vedotin + Adriamycin, Vinblastine, and Dacarbazine in Pediatric Participants With Advanced Stage Newly Diagnosed Hodgkin Lymphoma treatment 1 / 2 active_not_recruiting NCT04629430
Effects of Prebiotics on Gut Microbiome in Patients Undergoing HSCT No drug interventions treatment Not Available completed NCT01764230
Prevention of Ovarian Function Damage by a GnRH Analogue During Chemotherapy in Hodgkin Lymphoma Patients supportive_care Not Available completed NCT00909948
Intentional Rejection of the Donor Graft Using Recipient Leukocyte Infusion(s) Following Nonmyeloablative Allogeneic Stem Cell Transplant No drug interventions treatment 1 terminated NCT00025662
Selective T-Cell Depletion to Reduce GVHD (Patients) Receiving Stem Cell Tx to Treat Leukemia, Lymphoma or MDS No drug interventions treatment 2 completed NCT00393380
Study of Parathyroid Hormone Following Sequential Cord Blood Transplantation From an Unrelated Donor prevention 2 terminated NCT06116929
Hodgkin's Disease and Chemotherapy Before 40 Years No drug interventions prevention Not Available not_yet_recruiting NCT00534989
Use of FDG PET as Predictor of Residual Disease and Subsequent Relapse in Patients With NHL and HD Undergoing HDC and ASCT No drug interventions treatment Not Available completed NCT05544968
CD30biAb-AATC for CD30+ Malignancies No drug interventions treatment 1 / 2 not_yet_recruiting NCT01343368
Preservation of Ovarian Function After Hematopoietic Cell Transplant supportive_care 2 terminated NCT00062868
LMP-specific T-cells for Patients With Relapsed EBV-positive Lymphoma No drug interventions treatment 1 completed NCT02927769
A Study of Nivolumab Plus Brentuximab Vedotin in Patients Between 5 and 30 Years Old, With Hodgkin's Lymphoma (cHL), Relapsed or Refractory From First Line Treatment treatment 2 completed NCT02686346
Brentuximab Vedotin in Refractory/Relapsed Hodgkin Lymphoma Treated by ICE treatment 1 / 2 completed NCT00444912
The Effect of Rituximab on Mobilization With AMD3100 (Plerixafor) Plus G-CSF in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma (NHL) or Hodgkin Disease (HD) treatment 2 completed NCT00039910
Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia No drug interventions prevention 3 completed NCT03755414
Study of Itacitinib for the Prophylaxis of Graft-Versus-Host Disease and Cytokine Release Syndrome After T-cell Replete Haploidentical Peripheral Blood Hematopoietic Cell Transplantation treatment 1 completed NCT05188755
Fitness Assessment in Young Adults Recovered From Lymphoma No drug interventions diagnostic Not Available completed NCT01078350
Consent for Obtaining Additional Tissue at the Time of a Diagnostic Biopsy No drug interventions Not Available Not Available completed NCT03598608
Study to Evaluate the Safety and Efficacy of a Combination of Favezelimab (MK-4280) and Pembrolizumab (MK-3475) in Participants With Hematologic Malignancies (MK-4280-003) treatment 1 / 2 recruiting NCT02181738
Study of Nivolumab in Patients With Classical Hodgkin's Lymphoma (Registrational) treatment 2 completed NCT01207921
Lenalidomide Maintenance Therapy Post Autologous Transplant for Hodgkins Lymphoma treatment 1 completed NCT00871702
Infusion of Genetically Modified T Cell for Post Transplant Patients With Relapsed Disease No drug interventions treatment 1 completed NCT01745354
Immunostimulatory CpG SD-101 + RT in Recurrent/Progressive Lymphoma After Allogeneic Hematopoietic Cell Transplantation (HCT) No drug interventions treatment 1 terminated NCT00186251
High Dose Chemotherapy Followed By PBSC Rescue for HD No drug interventions treatment Not Available completed NCT00051597
A Safety/Efficacy Study of SGN-30 (Antibody) in Patients With Refractory or Recurrent CD30+ Hematologic Malignancies treatment 1 / 2 completed NCT02663297
Administration of T Lymphocytes for Prevention of Relapse of Lymphomas No drug interventions treatment 1 active_not_recruiting NCT03527628
OPTmizing Advanced Stage HodgkIn LymphoMa patIentS Therapy treatment 2 unknown_status NCT02287311
Most Closely Matched 3rd Party Rapidly Generated LMP, BARF1 And EBNA1 Specific CTL, EBV-Positive Lymphoma (MABEL) treatment 1 recruiting NCT00398411
Moxifloxacin in the Prevention of Bacteremia After High-dose Chemotherapy and Transplantation of Peripheral Stem Cells prevention 3 completed NCT00636311
A Phase II Study of IGEV +/- Bortezomib Before Hign Dose Consolidation in Relapsed/Refractory Hodgkin's Lymphoma treatment 2 completed NCT01468311
Yttrium-90-labeled Daclizumab With Chemotherapy and Stem Cell Transplant for Hodgkin's Lymphoma treatment 1 / 2 terminated NCT00540007
Lenalidomide in Relapsed or Refractory Classical Hodgkin Lymphoma treatment 2 completed NCT01716806
A Study of Brentuximab Vedotin With Hodgkin Lymphoma (HL) and CD30-expressing Peripheral T-cell Lymphoma (PTCL) treatment 2 completed NCT00188149
Optimization of the Primary Therapy for Patients With Hodgkin's Disease and Evaluation of PET No drug interventions treatment 4 unknown_status NCT00388349
Gemcitabine and Hodgkin's Disease Chemotherapy Followed by Peripheral Blood Stem Cell Rescue for Hodgkin's Disease treatment 2 completed NCT01135849
B-Receptor Signaling in Cardiomyopathy No drug interventions Not Available Not Available completed NCT02867618
Carfilzomib and TGR-1202 in Treatment of R/R Lymphoma treatment 1 / 2 terminated NCT00148018
Study of Bortezomib (Velcade) in Combination With Dexamethasone to Treat Patients With Relapsed Hodgkin's Lymphoma treatment 2 terminated NCT06093334
Imaging of Chemotherapy-induced Morphological and Functional Lung Changes in Childhood ALL and HD No drug interventions diagnostic Not Available recruiting NCT00562224
Study of the Safety and Tolerability of Oral Capsule Form of PCI-24781 in Advanced Cancer Patients treatment 1 completed NCT00113724
Study of TPI 287 in Patients With Advanced Malignancies treatment 1 completed NCT04459416
Managing Pain and Symptom Burden Caused by Chemotherapy in People With Myeloma or Lymphoma No drug interventions treatment 3 active_not_recruiting NCT01969435
Study of Melphalan HCl for Injection (Propylene Glycol-free), Carmustine, Etoposide, Cytarabine (BEAM Regimen) and Autologous Stem Cell Transplantation for Lymphoma treatment 2 completed NCT03942263
A Study to Describe Treatment Patterns and Disease Control in Participants With cHL and sALCL in Routine Clinical Practice in the Russian Federation No drug interventions Not Available Not Available completed NCT02589548
Brazilian Prospective Hodgkin Lymphoma Registry No drug interventions Not Available Not Available unknown_status NCT01490957
Functional Assessment of Cancer Therapy - Bone Marrow Transplant No drug interventions Not Available Not Available unknown_status NCT01195766
Study of Ofatumumab and ESHAP for the Treatment of Hodgkin's Lymphoma treatment 2 completed NCT00534820
Cytogenetic Analysis of Bone Marrow Specimen Prior to High Dose Chemotherapy and Autologous Stem Cell Transplantation in Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease No drug interventions basic_science Not Available completed NCT01121120
Acceleration of Platelet Recovery Following Autologous Peripheral Blood Stem Cell Transplant (PBSC) in Hodgkin, Non-Hodgkin Lymphoma or Multiple Myeloma Patients supportive_care 2 terminated NCT03935282
Assessing Effectiveness and Implementation of an EHR Tool to Assess Heart Health Among Survivors No drug interventions supportive_care Not Available active_not_recruiting NCT00058773
Giving Gene Marked EBV Specific T-Cells to Patients Receiving a BMT for Relapsed EBV-Positive Hodgkin Disease No drug interventions treatment 1 terminated NCT00225173
Combination Chemotherapy +/- Radiation in High Risk Hodgkin's Disease treatment 2 terminated NCT02104427
PD and Safety of TG-0054 Combined With G-CSF in Multiple Myeloma, Non-Hodgkin Lymphoma and Hodgkin Disease Patients treatment 2 completed NCT03838627
Feasibility and Agreement of Remote Evaluation of Resting Heart Rate and Heart Rate Variability in Survivors of Hodgkin Lymphoma Treated With Chest Radiation (PILOT STUDY-SURVIVOR) No drug interventions Not Available Not Available completed NCT00275262
A Study to Evaluate the Ability of Lupron Depot to Enhance Immune Function Following Bone Marrow Transplantation treatment 2 terminated NCT02389101
Molecular and Whole-body MR Imaging in Lymphomas No drug interventions diagnostic Not Available completed NCT01149668
A Safety and Tolerability Study of PCI-24781 in Subjects With Cancer treatment 1 completed NCT00901069
Azacitidine With Rituximab, Vincristine, and Cyclophosphamide in Refractory Lymphoma treatment 1 completed NCT01333046
Administration of TAA-Specific CTLs; Hodgkin or Non-Hodgkin Lymphoma; TACTAL treatment 1 active_not_recruiting NCT02939014
Brentuximab Vedotin in Chinese Participants With Relapsed/Refractory CD30-Positive Hodgkin Lymphoma (HL) or Systemic Anaplastic Large Cell Lymphoma (sALCL) treatment 2 completed NCT00026208
Combination Chemotherapy Plus Low-Dose Radiation Therapy in Treating Patients With Stage I or Stage IIA Hodgkin's Lymphoma treatment 2 completed NCT02885038
Effect of Product Related Factors on Platelet Concentrate Transfusion Response in Patients With Hematologic Malignacies No drug interventions Not Available Not Available completed